Dried Blood Spot Collection Cards Market Size to Reach USD 373.6 Million in 2028, Says Reports and Data

Increasing implementation of newborn screening programs mandated by governments, extensive R&D to develop advanced products, and surge in neonatal diseases and disorders are key factors driving market growth.

Increasing implementation of newborn screening programs mandated by governments, extensive R&D to develop advanced products, and surge in neonatal diseases and disorders are key factors driving market growth

The global dried blood spot collection cards market size is expected to reach USD 373.6 Million in 2028 at a CAGR of 3.8%, according to the latest report by Reports and Data. Increasing use of dried blood spot testing in resource-limited settings, rising demand for newborn screening, increasing application of dried blood spot testing for HIV surveillance, and rising prevalence of infectious diseases are some key factors expected to drive market revenue growth over the forecast period. In addition, increasing automation in analytical laboratories, less risk of biohazard, and easier storage as compared to liquid samples are also expected to contribute to market revenue growth going ahead.

Dried Blood Spots (DBS) refers to a whole blood sampling technique that uses small volumes of blood spotted on filter paper that are dried and analyzed. The technique was primarily developed to detect genetic metabolic disorder, phenylketonuria, in newborn babies. The technique has now been explored for various other applications including pharmacokinetic and toxicology studies and therapeutic drug monitoring to reduce expenses incurred during drug discovery and development processes. DBS testing offers numerous advantages over conventional testing such as minimal invasiveness, low volume of sample required, utilizes simple storage methods, minimal shipping expenses, and low risk of blood borne pathogens. Over the recent past, the interest in dried blood spot cards has increased exponentially and has expanded scope of global health and disease surveillance programs in low-resource settings and unreachable areas of the world.

In addition, lack of proper infrastructure for quality-assured venipuncture has boosted demand for dried blood spot cards in countries across the globe. Commercially available DBS cards are predominantly used in newborn screening and preclinical drug discovery and development within controlled clinical settings. One of the most popular DBS cards is the Whatman 903 card, which is made from cotton-based filter paper enclosed within rigid cardboard frame. Another major card is the FTA card, which is also a cotton-based cellulose paper that contains chemicals that burst cells, denature proteins, and stabilize nucleic acids such as DNA, which maintains the sample for molecular identification with no risk of contamination. These cards are also extensively used in forensic science and this trend is expected to remain prevalent over the forecast period.

Advantages such as requirement for low volume of blood, decreased risk of contamination and biohazards, and long-term conservation of blood sports with no deterioration of analytes are also factors fueling revenue growth of the market. However, inadequate blood sample volume, potential of sample contamination during handling, expensive dried blood spots testing, and incorrect selection of cards are other factors that can hamper market growth to a certain extent during the forecast period.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4054

Some Key Highlights From the Report:

  • FTA card segment is expected to register robust revenue growth over the forecast period owing to its attribute of allowing multiple application of same specimen on one card and independent processing of different samples. FTA cards are equipped with chemicals that lyse cells, denature proteins, and protect nucleic acids from damage and are immobilized for transport, immediate processing, or long-term storage. This is also expected to contribute to revenue growth of the segment.
  • Newborn screening segment is expected to account for largest market share in terms of revenue over the forecast period owing to increasing efficiency of dried blood spot cards to detect congenital and metabolic disorders in infants, non-invasive procedure, and easy understanding of follow-up and testing. In addition, samples for newborn screening are collected after birth and before exposure to external factors and this increases precision of DBS testing for newborn screening.
  • Europe is expected to register robust revenue growth over the forecast period, attributable to increasing incidence of hepatitis B, infectious diseases, congenital defects, development of advanced healthcare and research facilities, and increasing R&D investment to develop more advanced and innovative products.
  • Major companies in the market include Qiagen, PerkinElmer, Inc., Roche AG, Shimadzu Corporation (Novilytic Labs), Ahlstrom-Munksjö, Pall Corporation, Eastern Business Forms, Inc., ARCHIMEDlife, and Centogene AG.
  • In January 2021, Capitainer, which is a medical device company based in Sweden, announced closing of a financing round at USD 3.7 Million to launch its qDBS dried-blood-spot testing system. The system allows at-home collection of dried blood spot on a collection card that is equipped with microchannel that forms a high-quality dried blood spot sample for quantitative analysis.

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/4054

For the purpose of this report, Reports and Data has segmented the dried blood spot collection cards market based on card type, application, and region:

Card Type Outlook (Revenue, USD Million; 2018-2028)

  • Whatman 903
  • FTA
  • Ahlstrom 226
  • Others

Application Outlook (Revenue, USD Million; 2018-2028)

  • Newborn Screening
  • Infectious Disease Testing
  • Therapeutic Drug Monitoring
  • Forensics
  • Others

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/4054

Regional Outlook (Revenue, USD Million; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Explore Reports and Data’s Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Blood and Organ Bank Market Size, Share & Analysis, By Type (Red Blood Cell Collection, Processing and Distribution Services, Blood Plasma Collection, Processing and Distribution Services, Organ Bank Services, Tissue Bank Services, Health Screening Services, All Other Human Blood Services, Reproductive And Stem Cell Bank Services), By End-User (Hospitals, Diagnostic Centers, Blood Banks, Others), And By Region Forecast To 2027

Medical Refrigerators Market By Type (Plasma Freezers, Blood Bank Refrigerators, Lab Refrigerators, Lab Freezers, Ultra-low Temperature Freezers, Shock Freezers), Application Type (Blood Bank, Pharmacies, Hospitals, Research Labs, Diagnostics Centers), Forecast To 2027

Glycosylated Hemoglobin and C-Peptide Market Information By Product (Capsules, Tablets, Others), By Application (Diabetes, Oncology, Blood Disorders), By End-user (Hospitals, Research Institutions, Physical Examination Institutions, Others), By Region, Forecast to 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-dried-blood-spot-collection-cards-market